Workflow
全系列罐式集装箱
icon
Search documents
中集环科:公司主要产品包括全系列罐式集装箱
Zheng Quan Ri Bao Wang· 2025-12-18 13:12
证券日报网12月18日讯中集环科(301559)在12月17日回答调研者提问时表示,公司主要产品包括全系 列罐式集装箱,涵盖标准不锈钢液体罐箱、特种不锈钢液体罐箱、碳钢气体罐箱、碳钢粉末罐箱等。标 准不锈钢液体罐箱通常指按照国际标准20英尺尺寸设计的通用不锈钢液体罐箱。相较于特种罐箱,标箱 主要运输大宗化工品。特种不锈钢液体罐箱是根据客户个性化需求,在尺寸、功能等方面进行特殊配置 处理的不锈钢液体罐箱。尺寸方面,主要应客户需求,开发出超大容积铁路罐箱、方圆罐箱等,此类罐 箱需求来源于区域化运输,如欧洲内陆运输、中国铁路运输等。功能方面,应客户要求,开发出专业化 工品(电解液、电子级氢氟酸等)运输罐箱、专业食品运输罐箱。碳钢罐箱主要用于气体及粉末等特殊介 质的储运,具有高强度、高耐腐蚀性、抗压性能优异、使用寿命长等比较优势。碳钢罐箱运输的主要产 品包括制冷剂、高纯液氨等。 ...
中集环科(301559) - 2025年12月9日投资者关系活动记录表
2025-12-09 10:16
Group 1: Company Overview - The company specializes in the design, research and development, manufacturing, and sales of tank containers, being a global leader in liquid and liquefied gas container logistics equipment and lifecycle services [1] - In 2025, the company faced challenges due to uncertainties in U.S. trade policies and global geopolitical tensions, leading to a complex economic situation impacting the downstream chemical industry [2] Group 2: Market Performance - The tank container business maintained the top market share, with revenue of CNY 1,313.24 million in the first three quarters of 2025 [2] - The after-market services generated revenue of CNY 112.45 million, reflecting a year-on-year increase of 3.52% [4] - The medical equipment components business achieved revenue of CNY 181.44 million, up 5.92% year-on-year [5] Group 3: Product Offerings - The company offers a full range of tank containers, including standard stainless steel liquid tanks, special stainless steel liquid tanks, carbon steel gas tanks, and carbon steel powder tanks [2] - Standard stainless steel liquid tanks are designed for bulk chemical transportation, while special tanks are customized based on client needs [2] Group 4: Future Development Strategy - The company aims to diversify its business to ensure sustainable growth and enhance risk resistance, focusing on high-end equipment and intelligent manufacturing [6][7] - Plans include expanding into high-end medical equipment and smart equipment sectors, leveraging advanced technologies and market opportunities [6][7] Group 5: Dividend Policy - The company has established a shareholder dividend return plan for 2024-2026, committing to distribute at least 50% of the annual distributable profits as cash dividends [7] - In 2024, the company plans to distribute CNY 4.4 per 10 shares, totaling CNY 264 million [7]
中集环科(301559) - 2025年5月15日投资者关系活动记录表
2025-05-15 12:24
Group 1: Company Overview - CIMC Enric is a subsidiary of CIMC Group, primarily engaged in the design, research and development, manufacturing, and sales of tank containers, making it a global leader in liquid and liquefied gas container logistics equipment manufacturing and lifecycle services [1] - In Q1 2025, the company achieved operating revenue of CNY 611.23 million, a decrease of 1.31% year-on-year [1] - Revenue from tank containers was CNY 480.76 million, down 2.57% year-on-year; medical device components revenue was CNY 54.41 million, up 20.98% year-on-year; aftermarket business revenue was CNY 36.08 million, up 0.15% year-on-year [1] Group 2: Business Performance - The tank container business maintained its market position, while the medical device components business continued to show double-digit growth [2] - The company reported a significant improvement in operating cash flow and a double-digit growth in new orders year-on-year [2] Group 3: Product and Market Insights - The main products include a full range of tank containers, such as standard stainless steel liquid tanks, special stainless steel liquid tanks, carbon steel gas tanks, and carbon steel powder tanks [2] - The standard stainless steel liquid tank is designed according to international standards and is primarily used for transporting bulk chemical products [2] - The company anticipates challenges in 2025 due to geopolitical uncertainties and new trade policies affecting global economic recovery [2][3] Group 4: Future Outlook - In Q1 2025, new orders increased by 17.27% year-on-year, indicating a positive market demand [3] - The medical device components business is expected to continue its growth trajectory, with plans for increased R&D and investment in this sector [3]